To mark World Health Day, VML Health has published a new report which highlights the contradictions and opportunities for pharmaceutical companies seeking to better connect with patients and healthcare professionals. 

In an era in which healthcare marketing is rising up the broader marketing agenda, reflected by the influx of pharmaceutical brands in coveted Superbowl marketing spots, the report helps marketing leaders navigate a complex consumer landscape. 

The ‘Health Futures’ report draws data from key trends identified in VML's Future 100 report for 2025 and explores their potential impact on health and pharma. 

It recognises 2025 as a year of consumer contradictions. While consumers crave stability and human connection, there is also the digital reality of the increased blurring of lines between humanity and technology. This tension, coupled with the fact that over half of today's ads fail to spark an emotional reaction, underscores the complex landscape that pharma companies seek to communicate within while contributing to a healthier society.

The Health Futures analysis asks, if only 13% of consumers strongly believe brands provide accurate information, how do pharmaceutical companies connect with increasingly discerning patients and healthcare professionals?

"Health Futures reminds us that whilst access to reliable health information is considered a fundamental right, patients are also becoming more discerning in their healthcare choices," explains Jason Gloye, Global Chief Client Officer and Head of North America at VML Health. 

He continues: "Our analysis highlights some of the challenges presented to the health sector from some of the world's wider trends. Trends such as the 'Brand Paradox' which asks brands to embrace bold storytelling ideas but at the same time focus on honesty and efficacy. With more than half of today’s ads failing to spark an emotional reaction, and 73% of consumers wanting brands to make more effort to entertain them, the risk of being forgettable could be just as dangerous as being untrustworthy.”

The report unpacks five key trends and their impact on the health and pharmaceutical sector. These include ‘The Brand Paradox’, which underlines the tightrope brands must walk between humility and showmanship. In essence, brands must balance authenticity and spectacle to build trust. However, while the research underlines that consumers crave realness and relatability, they also want to be wowed with bold, imaginative storytelling.

A similar tension is underlined in the ‘Analog Movement’ trend. Consumers are seeking tactile, real-world experiences in response to online burnout, creating opportunities for in-person engagement and sensory-rich activities. Yet at the same time, ‘Reality Shift’ is highlighted as a key shift. As virtual health and metaverse experiences grow, younger generations explore reality-shifting practices, immersing themselves in alternative virtual experiences. Calling for brands to proactively combat misinformation and establish trust.

Other core trends include ‘Selective Healthcare’. According to the report, patients are becoming more selective in their treatment choices, demanding greater value and personalized approaches. This means health brands need to demonstrate why their treatments are worth prioritizing, moving beyond broad access conversations to align with real-world patient decision-making.

Superforecasters is another shift highlighted in the report, which pinpoints the need to integrate AI-assisted forecasting with human expertise to navigate complex timelines involving drug development and the management of different regulatory landscapes.

The report unpacks how these trends demand a fundamental shift in how pharmaceutical brands engage with consumers.

While patient-centricity remains paramount, the report underlines a shift towards immersive online experiences and AI-driven interactions to deliver truly personalized education and foster authentic community connections.

"In a landscape where healthcare decisions are increasingly discretionary, the industry must move away from a volume-driven mindset toward a more intentional, outcome-based narrative," adds Gloye.

He continues: "Positioning treatments not as more healthcare, but as the right healthcare, at the right moment, for the right reasons, is essential for building trust, empowering patients, and contributing to a healthier world. All aligning perfectly with the goals of World Health Day."

To read more from the Health Futures report, please download it here.